$25.94
-0.35-1.33%
al cierre: Nov 19, 4:00 PM EST
jueves, noviembre 20
Comments
Loading...
iShares Genomics Immunology and Healthcare ETF (IDNA) Precio de Acción, Cotización, Noticias e Historial
IDNAARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
126.08M
Fund Score
Estadísticas Clave
Apertura
$26.31
Máximo
$26.31
Máximo de 52 semanas
$26.48
AUM
126.08M
Dividendo
$0.26
Fecha Ex-Div
jun 16, 2025
Volumen
13.47K
Capitalización bursátil
$16.19B
Tarifa de gestión
0.47%
Ratio PER
12.41
Cierre anterior
$26.29
Mínimo
$25.86
Mínimo de 52 semanas
$17.26
Acciones en circulación
5.85M
Rendimiento
1.24%
Frec. de Div.
S
Promedio Volumen diario
30.90K
Beta
1.01
Promedio Relación de gastos
0.47%
Relación P/B
2.35
Noticias Recientes de iShares Genomics Immunology and Healthcare ETF
PREGUNTAS FRECUENTES
Q
¿Cómo puedo comprar la acción de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
Puedes comprar acciones de iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) a través de cualquier corretaje en línea.
Q
¿Quiénes son los competidores de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
No hay competidores como tal para iShares Genomics Immunology and Healthcare ETF.
Q
¿Cuál es el pronóstico o precio objetivo para las acciones de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
No existe ningún análisis de iShares Genomics Immunology and Healthcare ETF que proporcione un precio objetivo de consenso.
Q
¿Cuál es el precio actual de las acciones de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
El precio de las acciones de iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) es de dólares, actualizado por última vez el .
Q
¿iShares Genomics Immunology and Healthcare ETF (IDNA) paga dividendos?
A
No hay dividendos previstos para iShares Genomics Immunology and Healthcare ETF.
Q
¿Cuándo iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) publicará los resultados?
A
No hay informes de resultados previstos para iShares Genomics Immunology and Healthcare ETF.
Q
¿iShares Genomics Immunology and Healthcare ETF (IDNA) se va a dividir?
A
No hay ninguna división de acciones prevista para iShares Genomics Immunology and Healthcare ETF.
Estadísticas Clave
Apertura
$26.31
Máximo
$26.31
Máximo de 52 semanas
$26.48
AUM
126.08M
Dividendo
$0.26
Fecha Ex-Div
jun 16, 2025
Volumen
13.47K
Capitalización bursátil
$16.19B
Tarifa de gestión
0.47%
Ratio PER
12.41
Cierre anterior
$26.29
Mínimo
$25.86
Mínimo de 52 semanas
$17.26
Acciones en circulación
5.85M
Rendimiento
1.24%
Frec. de Div.
S
Promedio Volumen diario
30.90K
Beta
1.01
Promedio Relación de gastos
0.47%
Relación P/B
2.35
Acerca de
Sector
NULO
Industria
NULO
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | jun 11, 2019 |
| Managers | Matt Waldron Jennifer Hsui Paul Whitehead |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| SM | Roche Holding A.G. | 3.76% |
| GILD | Gilead Sciences Inc | 4.62% |
| SRPT | Sarepta Therapeutics I... | 4.53% |
| RVMD | Revolution Medicines I... | 4.98% |
| INCY | Incyte Corp. | 4.73% |
| REGN | Regeneron Pharmaceutic... | 4.60% |
| EXEL | Exelixis Inc | 5.97% |
| TK | Takeda Pharmaceutical ... | 4.04% |
| PA | Sanofi SA | 3.92% |
| HK | Beigene, Ltd. | 4.18% |
| SWTX | Springworks Therapeuti... | 5.08% |
| LN | GSK plc | 3.97% |
| CO | Genmab A.S. | 4.48% |
| MRK | Merck & Co. Inc. | 3.79% |
| FF | Biontech Se | 4.10% |
| MRNA | Moderna therapeutics | 4.46% |
| TWST | Twist Bioscience Corp. | 4.40% |
| ACLX | Arcellx, Inc. | 4.61% |
| CELC | Celcuity Inc Common St... | 4.68% |
SOCIO/CONTRIBUIDOR
© 2025 Benzinga | All Rights Reserved